Epic Sciences on Sept. 12 hauled in a $52 million Series E round to advance a portfolio of tests. The round was led by Blue Ox Healthcare Partners, with participation by Deerfield Management and Varian. Existing investors, including Altos …
Quote saved.
Login to quote this blog
Failed to save quote. Please try again later.
You cannot quote because this article is private.